Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2014


4TH ANNUAL Biosimilar Conference

24 Mar 2014 - 25 Mar 2014 - Boston, MA, USA



Bookmark and Share


4TH ANNUAL Biosimilar Conference

Exploring possibilities... What the future holds for biosimilar development and regulation

24th - 25th March 2014 in Boston USA

BOOK NOW

Speakers: 

John Doyle Senior Vice President and Managing Director, Global Market Access & Commercialization Quintiles

Steven Grossman Public policy and FDA regulatory consultant at FDA Matters, HPS Group, LLC

Robert Ward VP Head of Strategy; New Opportunities AstraZeneca

John Pakulski Head Biopharmaceutical Regulatory Affairs at Sandoz Pharmaceuticals

Joerg Bluemel, PhD Director Toxicology at MedImmune, Board Certified Toxicologist

Peter Pitts President Center for Medicine in the Public Interest

Chief Regulatory Officer at Adherent Health, LLC.

Paul Calvo Director at Sterne, Kessler, Goldstein & Fox

Angela Amend Kwasnik Global Product Director, Merck BioVentures at Merck & Co., Inc.

James Harris CEO at Healthcare Economics LLC



Further information
Scientific News
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
UTSW Researchers Identifies How Drugs Alter Pancreatic Cancer Cells
The findings were published in Cell Reports.
Researchers Identify Process that Causes Chronic Neonatal Lung Disease
Study determines how the NLRP3 inflammasome activates the protein Interleukin 1 beta.
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Trying to Conceive Soon After a Pregnancy Loss May Increase Chances of Live Birth
NIH study finds no reason for delaying pregnancy attempts after a loss without complications.
BRCA1 Deficiency Increases the Sensitivity of Ovarian Cancer Cells to Auranofin
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
Shingles Vaccine Helps Protect Older Patients with End-stage Renal Disease
Kaiser Permanente study advances knowledge about safety and effectiveness of vaccine commonly given to older adults.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!